close
MENU
How to guide
How to guide
Home
The NBR Rich List
NBR Marketplace
NBR Video

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Marketing & Media Tourism Energy Luxury Property Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

NBR Marketplace Local Edge NBR Video Toil & Trouble Beehive Banter Morning Brew Dollars & Sense Entrepreneurs The Grind Market Outlook Executive Health Market Review Students’ Say The NBR Podcast Opinion (Archive) NBR Radar (Archive) Private Bin NZ Aviation News (Archive) NBR Rich List (Archive) Your Business Audio Articles The NBR Rich List
Latest
Related
Morning Brew
3

Stocks rally on potential US-China pact; Trump coy on third term
Underarm
2

Albanese gets a big welcome and survives the Trump test
Underarm
4

Aussie rare earths industry a winner from US-China standoff
Politics
2

Govt adds gold and coal to critical minerals list
Book Review
9

Rare metals open door to mining’s new dawn
Shoeshine
9

Housing projects face winter of discontent

ANALYSIS: Lack of presales, reluctant funders, construction challenges leading to world of pain for small-scale residential developers.

Maria Slade Mon, 17 Oct 2022
Shoeshine
1

Sure to rise: can new My Food Bag CEO deliver?

ANALYSIS: Kevin Bowler’s unexpected resignation as CEO last month gives much-maligned company a golden opportunity.

Hamish McNicol Mon, 10 Oct 2022
Shoeshine
5

Is Southern Cross squeezing the lemon too hard on fees?

ANALYSIS: One medical provider speaks out; Southern Cross says it’s no bully.

Fiona Rotherham Mon, 03 Oct 2022
Shoeshine
2

Supermarkets benevolently swallow the cost of inflation

ANALYSIS: Or do they? Supermarkets and suppliers locked in battle of wits.

Dita De Boni Tue, 27 Sep 2022
Shoeshine
3

Homegrown pharmaceutical firm takes long view

ANALYSIS: Let Douglas Pharmaceuticals not be an outlier in New Zealand’s promising health tech sector.

Maria Slade Mon, 19 Sep 2022
Shoeshine

Earnings season beats expectations but worst is yet to come

ANALYSIS: Headwinds as strong as ever despite listed companies reporting generally positive financial results.

Hamish McNicol Mon, 12 Sep 2022
Shoeshine

The new broom at global health IT provider Orion Health

ANALYSIS: ‘As I say to them, don’t mess it up,’ says founder and former CEO Ian McCrae.

Fiona Rotherham Mon, 05 Sep 2022
Shoeshine

Who are the Edmund Hillary Fellows?

Scheme to boost New Zealand’s entrepreneurial vitality welcomes latest cohort of recruits.

Will Mace Mon, 29 Aug 2022
Shoeshine
5

Another one gets away from the NZX

Partners Life's massive $1b sale should be celebrated, but has left some wondering what could have been.

Hamish McNicol Mon, 22 Aug 2022
1 15 16 17 18 19 57
Most Popular
Most Commented
Book Review

Taming the dragon: Can China keep going?

Weekly Wrap: Entrepreneurs, capital gains, ending employment
Investment

New Spark director may have the Wright stuff to replace Smyth
Last Word
1

Why Chicago was NZ Rugby’s biggest test yet
Investment

Dual Australian/NZ listing isn’t Vital, on liquidity concerns
General Business

Maersk ‘reviews’ Lyttelton visits as industrial action steams on
Politics
25

Barbara Edmonds defends Labour’s new CGT policy
Politics
20

NZGIF writes off $133m on SolarZero
Investment
10

Simplicity touts KiwiSaver-backed listed infrastructure fund
General Business
5

What David Kirk is looking for in NZ Rugby’s next CEO
Law
4

Damien Grant tried to get judge recused in Stanley Group dispute

Tech & Innovation
4

Being AI broaches Send Global sale to Evan Christian for $8.8m
Subscribe Login